Fundz

Vitrivax Announces Series A Financing To Further Demonstrate Feasibility Of Its Thermostable, Single-Dose Vaccine Technology, Aiming To Make Life-Saving Biologics Widely Accessible To Underserved Populations Globally

PRIVATEJul 07, 2021

Round Type

Series A

BoulderBiotechnologyTherapeutics

Description

VitriVax, developer of a novel stabilization and delivery platform for vaccines and therapeutics, today announced it has closed its first institutional financing round with Adjuvant Capital. Series A proceeds will be used to develop and commercialize a technology with the potential to eliminate barriers to global vaccine administration, extending their life-saving benefits to underserved populations and compressing multidose regimens into a single shot.

Quick answer

Vitri Vax raised an undisclosed amount in a Series A round, dated July 7, 2021. Vitri Vax is based in Boulder, Colorado, United States.

How much did Vitri Vax raise?
Vitri Vax raised an undisclosed amount in a Series A round on July 7, 2021.
What does Vitri Vax do?
VitriVax is a Boulder, Colorado- and Boston, Massachusetts-based biotechnology company working to eliminate barriers to global vaccination.
Where is Vitri Vax based and how big is it?
Vitri Vax is based in Boulder, Colorado, United States.
Who are the decision-makers at Vitri Vax?
Fundz holds 1 contact at Vitri Vax. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Vitri Vax that raised within 45 days of this round, from Fundz verified event records.

  • ADARx Pharmaceuticals, Inc. raised $75M on August 17, 2021.
  • GentiBio raised $157M (Series A) on August 11, 2021.
  • Renovacor, Inc. raised $2.5M (Seed) on August 4, 2021.
  • Turnstone Biologics Corp raised $80M (Series D) on July 21, 2021.
  • Amylyx Pharmaceuticals raised $135M (Series C) on July 20, 2021.
  • Century Therapeutics raised $11M on July 19, 2021.

Who to call at Vitri Vax, and when

A new round usually means Vitri Vax is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vitri Vax raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vitri Vax, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vitri Vax. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vitri Vax

Location

Boulder, Colorado, United States

About

VitriVax is a Boulder, Colorado- and Boston, Massachusetts-based biotechnology company working to eliminate barriers to global vaccination. VitriVax partners with vaccine developers to formulate their vaccines to be thermostable and delivered in a single shot. Products formulated by the VitriVax ALTATM platform can be shipped globally without refrigeration or freezing, last for years on the shelf, and only require one patient interaction to deliver multiple doses. For more information, visit www.vitrivaxbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vitri Vax raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Vitri Vax's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Vitri Vax raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.